# Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC

**Authors:** Ibrahim Azar, Nikhil Vojjala, Richa Parikh, Hari B. Keshava, Misako Nagasaka

PMC · DOI: 10.1055/a-2564-2186 · 2025-04-21

## Full-text entities

- **Diseases:** Stage IIIA (MESH:D062706), heart failure (MESH:D006333), stage IA, IB, II, or T3N1 disease (MESH:D007676), nodal (MESH:D013611), NSCLC (MESH:D002289), lung cancer (MESH:D008175), N2 disease (MESH:D004194)
- **Chemicals:** CM (MESH:D003476), durvalumab (MESH:C000613593)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12020623/full.md

---
Source: https://tomesphere.com/paper/PMC12020623